Abstracts tagged "Sjogren’s syndrome and classification criteria"

Abstract Number: 1469 • 2019 ACR/ARP Annual Meeting
New 2019 SLE EULAR/ACR Classification Criteria for SLE Are Valuable for Distinguishing Patients with SLE from Patients with pSS in Daily Practice
Florence Assan¹, Raphaele Seror ², Gaetane Nocturne ³ and Xavier Mariette ⁴, ¹Université Paris Sud, Hôpitaux Universitaires Paris-Sud, AP-HP, INSERM UMR 1184, Le Kremlin-Bicêtre, France, ²Hopitaux universitaires Paris Sud, Kremlin-Bicetre, France, ³Center for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Université Paris Sud, INSERM, Paris, France., Paris, France, ⁴Center for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Université Paris Sud, INSERM, Paris, France
Background/Purpose: The new 2019 SLE EULAR/ACR Classification Criteria for Systemic lupus erythematosus (SLE) have been developed to find a better equilibrium between specificity and sensitivity…
Abstract Number: 1493 • 2017 ACR/ARHP Annual Meeting
Characteristics of Korean Primary Sjogren’s Syndrome and Comparison of 3 Different Classification Criteria for Primary Sjogren’s Syndrome: Data from Korean Kiss Cohort
Ji-Won Kim¹, Jennifer Lee², Yeon-Sik Hong³, Sung-Hwan Park² and Ji Hyeon Ju², ¹Medicine, Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South), ²Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South), ³Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
Background/Purpose: The objective of this study is to introduce the clinical and laboratory characteristics of Korean primary Sjogren’s syndrome (pSS) patients enrolled in Korean Initiative…
Abstract Number: 1502 • 2017 ACR/ARHP Annual Meeting
Comparison of Classification Criteria for Sjögren’s Syndrome from 2002 and 2016 in an Incident Cohort Diagnosed 2007 to 2011 from Stockholm County Sweden
Marika Kvarnstrom¹ and Marie Wahren-Herlenius², ¹Unit of Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, ²Unit of Experimental Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden
Background/Purpose: Comparison of classification criteria for Sjögren's syndrome from 2002 and 2016 in a 5 year cohort of incident patients diagnosed 2007 to 2011 from…
Abstract Number: 2689 • 2016 ACR/ARHP Annual Meeting
Comparison of the 2016 ACR/EULAR and the 2002 AECG Classification Criteria in a Cohort of Patients with Suspected Primary SjöGren’s Syndrome
Divi Cornec¹, Maëlle Le Goff², Sandrine Jousse-Joulin³, Dewi Guellec⁴, Sebastian Costa⁵, Thierry Marhadour⁶, Jacques-Olivier Pers⁷, Alain Saraux⁸ and Valerie Devauchelle-Pensec⁹, ¹Department of rheumatology, Brest Occidentale University, Brest, France, ²CHRU Brest, Brest, France, ³Rheumatology, CHu La cavle Blanche, Brest, France, ⁴Rheumatology Department, CHU de la Cavale Blanche, Brest, France, ⁵anatomopathological department, Brest university hospital, Brest, France, ⁶Rheumatology, CHU La Cavale Blanche, Brest, France, ⁷INSERM ERI29, EA2216, Université de Brest, Labex IGO, CHRU Morvan, Brest, France, ⁸Rheumatology Department, CHU de la Cavale Blanche, Brest Cedex, France, ⁹Rheumatology Department, Brest University Hospital, Brest, France
Background/Purpose: New consensual classification criteria for primary Sjögren’s syndrome (pSS) have been recently developed, validated, and submitted to ACR and EULAR committees. They differ substantially…
Abstract Number: 2535 • 2014 ACR/ARHP Annual Meeting
Performance of the Ocular Staining Score (OSS) Vs. the Van Bijsterveld Score in the Assessment of Sjögren’s Syndrome-Related Keratoconjunctivitis Sicca
Astrid Rasmussen¹, Michael Brown¹, Donald U Stone², Keith Earley³, Kimberly S. Hefner⁴, Lida Radfar⁵, David M. Lewis⁶, Stephen Young⁶, Nelson L. Rhodus⁷, Barbara M. Segal⁸, Christopher J. Lessard⁹, Courtney G. Montgomery¹⁰, R. Hal Scofield¹¹ and Kathy L. Sivils¹², ¹Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, ²Dean McGee Eye Institute, Oklahoma City, OK, ³US Air Force, Oklahoma City, OK, ⁴Hefner Eye Care and Optical Center, Oklahoma City, OK, ⁵College of Dentristry, University of Oklahoma Health Sciences Center, Oklahoma City, OK, ⁶College of Dentistry, University of Oklahoma Health Sciences Center, Oklahoma City, OK, ⁷University of Minnesota, Minneapolis, MN, ⁸Rheumatology, Hennepin County Medical Center, Minneapolis, MN, ⁹825 N.E. 13th St., Oklahoma Medical Research Foundation, Oklahoma City, OK, ¹⁰Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, ¹¹US Department of Veterans Affairs Medical Center, Oklahoma City, OK, ¹²Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK
Background/Purpose: Sjögren’s syndrome (SS) is a complex autoimmune disorder characterized by xerostomia and xerophthalmia due to exocrine gland dysfunction. There is no single diagnostic test…
Abstract Number: 2202 • 2012 ACR/ARHP Annual Meeting
Classification Criteria for Sjögren’s Syndrome: Comparison of the Performance of the 2002 American-European Consensus Group Criteria (AECG) and the 2012 ACR Criteria
Elke Theander¹, Peter Olsson² and Thomas Mandl³, ¹Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, ²Section of Rheumatology, Department of Clinical Sciences, Lund University, Malmö, Sweden, ³Dept of Rheumatology, Skåne University Hospital Malmo, Lund University, Sweden, Malmö, Sweden
Background/Purpose: To assess level of agreement between 2002 AECC and 2012 ACR criteria for primary Sjögren's Syndrome syndrome (pSS) within the Malmö Sjögren's Syndrome RegistryMethods…
Abstract Number: 2203 • 2012 ACR/ARHP Annual Meeting
Effects of Reclassification Using the American College of Rheumatology Criteria On a Large cohort Sjögren’s Syndrome Patients
Astrid Rasmussen¹, John A. Ice¹, He Li², Kiely Grundahl³, Jennifer A. Kelly⁴, Lida Radfar⁵, Kimberly S. Hefner⁶, Donald U. Stone⁷, Juan-Manuel Anaya⁸, Michael Rohrer⁹, Glen D. Houston¹⁰, David M. Lewis¹¹, James Chodosh¹², John B. Harley¹³, Pamela Hughes⁹, Jacen S. Maier-Moore⁵, Courtney G. Montgomery¹, Nelson L. Rhodus¹⁴, A. Darise Farris¹⁵, Barbara M. Segal¹⁶, Christopher J. Lessard¹⁷, R. Hal Scofield¹⁸ and Kathy Moser Sivils⁴, ¹Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, ²Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma CIty, OK, ³Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, oklahoma CIty, OK, ⁴Oklahoma Medical Research Foundation, Oklahoma City, OK, ⁵University of Oklahoma Health Sciences Center, Oklahoma City, OK, ⁶Hefner Eye Care and Optical Center, Oklahoma City, OK, ⁷Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, ⁸School of Medicine and Health Sciences, Universidad del Rosario. Center for Autoimmune Diseases Research (CREA), Bogotá, Colombia, ⁹Diagnostic and Biological Sciences, University of Minnesota, Minneapolis, MN, ¹⁰Collage of Denistry, University of Oklahoma Health Sciences Center, Oklahoma City, OK, ¹¹College of Dentistry, University of Oklahoma Health Sciences Center, Oklahoma City, OK, ¹²Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, ¹³Division of Rheumatology and The Center for Autoimmune Genomics & Etiology, University of Cincinnati, Cincinnati Children's Hospital Medical Center; US Department of Veterans Affairs Medical Center, Cincinnati, OH, ¹⁴University of Minnesota, Minneapolis, MN, ¹⁵Arthritis & Immunology Program, Oklahoma Medical Research Foun, Oklahoma City, OK, ¹⁶Rheumatology, Hennepin County Medical Center, Minneapolis, MN, ¹⁷Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation; University of Oklahoma Health Sciences Center, Oklahoma City, OK, ¹⁸Arthritis & Immunology, Oklahoma Medical Research Foun, Oklahoma City, OK
Background/Purpose: There is no single clinical diagnostic test for primary Sjögren’s syndrome (pSS). For research purposes, multiple classification criteria have been proposed over the past…
Abstract Number: 2204 • 2012 ACR/ARHP Annual Meeting
Overall Agreement Between Sjögrens’s Minor Salivary Gland Biopsy and 2002 and 2012 Classification Criteria
Laura Aline Martinez¹, Candido Flores², Alberto Arana Fraustro³ and Luis H. Silveira⁴, ¹Rheumatology, Instituto Nacional de Cardiologia Ignacion Chavez, Mexico City, Mexico, ²Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, ³Pathology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, ⁴Rheumatology, Instituto Nacional Cardiología Ignacio Chávez, Mexico City, Mexico
Background/Purpose: Sjögren’s syndrome (SS) is an inflammatory autoimmune disease characterized by lymphoid infiltration of exocrine glands, although extraglandular involvement is frequently observed. Prevalence is around…
Abstract Number: 2205 • 2012 ACR/ARHP Annual Meeting
Longitudinal Evaluation of the Performance of Different Classification Criteria in Patients with Primary Sjögren’s Syndrome
Martina Plešivčnik Novljan¹, ŽIga Rotar², Aleš Ambrožič¹, Gaj Vidmar³ and Matija Tomšič¹, ¹Department of Rheumatology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia, ²Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, ³University Rehabilitation Institute, 1000 Ljubljana, Slovenia
Background/Purpose: Over the past 3 decades, 10 different classification criteria for Sjögren's syndrome (SS) had been proposed. In 2001 and 2002 222 consecutive patients suspected…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].